Company Filing History:
Years Active: 1993-2015
Title: The Innovations of Seth L. Alper
Introduction
Seth L. Alper is a notable inventor based in Boston, MA, with a significant contribution to the field of biomedical research. He holds a total of 8 patents, showcasing his innovative approaches to solving complex medical challenges. His work primarily focuses on improving health outcomes for individuals with specific medical conditions.
Latest Patents
Among his latest patents, one invention provides methods and compositions for inhibiting calcium permeable cation conductance of red blood cells from individuals afflicted with sickle cell anemia. This method involves exposing the cells to the peptide GsMTx4 and/or its variants. Another significant patent relates to vacuolar pyrophosphatases and their uses in plants. This invention describes a transgenic plant that is tolerant to salt, comprising one or more plant cells transformed with exogenous nucleic acid that alters the expression of vacuolar pyrophosphatase. Additionally, it encompasses transgenic progeny and seeds of the described transgenic plants.
Career Highlights
Seth L. Alper has had a distinguished career, working with reputable institutions such as Beth Israel Deaconess Medical Center and the University of Connecticut. His research has contributed to advancements in both medical and agricultural fields, demonstrating his versatility as an inventor.
Collaborations
Throughout his career, Alper has collaborated with esteemed colleagues, including Roberto A. Gaxiola and Gerald R. Fink. These partnerships have further enriched his research and innovation efforts.
Conclusion
Seth L. Alper's contributions to science and technology through his patents and collaborations highlight his role as a leading inventor in the biomedical field. His work continues to impact the lives of many, showcasing the importance of innovation in addressing health challenges.